- Home
- YALA vs ARDX Comparison
YALA vs ARDX Comparison
Compare YALA & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YALA | ARDX |
|---|---|---|
| Founded | 2016 | 2007 |
| Country | United Arab Emirates | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 844.2M | 862.3M |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | YALA | ARDX |
|---|---|---|
| Price | $5.41 | $3.40 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | $7.28 | ★ $12.90 |
| AVG Volume (30 Days) | 269.3K | ★ 3.9M |
| Earning Date | 11-09-2026 | 10-29-2026 |
| Dividend Yield | ★ 5.26% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,607,000.00 |
| Revenue This Year | $0.00 | $20.00 |
| Revenue Next Year | $12.03 | $27.64 |
| P/E Ratio | $8.76 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.01 | $3.31 |
| 52 Week High | $7.83 | $8.40 |
Technical Indicators
Market Signals| Indicator | YALA | ARDX |
|---|---|---|
| Relative Strength Index (RSI) | 46.35 | 33.58 |
| Support Level | $5.22 | $3.33 |
| Resistance Level | $5.63 | $3.63 |
| Average True Range (ATR) | 0.10 | 0.12 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 39.66 | 32.86 |
Price Performance
Historical ComparisonAbout YALA Yalla Group Limited each representing one
Yalla Group Ltd is a MENA-based online social networking and gaming company. It operates two flagship mobile applications, Yalla, a voice-centric group chat platform, and Yalla Ludo, a casual gaming application featuring online versions of board games popular in MENA, with in-game voice chat and localized majlis functions. The group has one operating segment, which is the social networking and entertainment platform.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. Its products Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.